BMC wins action against ResMed

Tuesday, February 9, 2016

BEJING – BMC Medical has won a global patent infringement litigation action against ResMed, it has announced. The U.S. Patent and Trademark Office issued a series of judgments in connection with inter partes review of U.S. Patent No. RE44453 on Jan. 21, 2016, and found 32 claims invalid, the company says. “We have now built a powerful patent team to support our strong resources in research and development,” stated Denny Wu, BMC’s head of intellectual property department. “In less than three years, we have applied for hundreds of patents and now we are able to proactively protect our rights and interests.”